Representative Rob Bresnahan urges DEA to emergency schedule chemically manipulated 7-OH, a potent kratom derivative with opioid-like effects.
Quiver AI Summary
Rep. Bresnahan calls for emergency action: On March 27, 2026, U.S. Representative Rob Bresnahan, Jr. sent a letter to the Drug Enforcement Administration (DEA) urging the immediate emergency scheduling of 7-hydroxymitragynine (7-OH), a derivative of kratom with opioid-like effects, to address public health risks associated with its rapid spread.
Concerns over addictive properties: In his letter, Bresnahan cited the dangers of high-potency 7-OH products, which appear in fast-acting forms like sublingual tablets and gummies, creating rapid feelings of euphoria and increasing addiction risks. He emphasized that swift regulatory action is necessary to protect consumers from these substances.
DEA's authority highlighted: Bresnahan stressed that the DEA's emergency scheduling authority would effectively halt the distribution of these synthetic products while further evaluations are conducted, citing concerns raised by previous FDA recommendations regarding their public health implications.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Robert Bresnahan Fundraising
Robert Bresnahan recently disclosed $381.6K of fundraising in a Q4 FEC disclosure filed on January 30th, 2026. This was the 239th most from all Q4 reports we have seen this year. 63.5% came from individual donors.
Bresnahan disclosed $311.9K of spending. This was the 220th most from all Q4 reports we have seen from politicians so far this year.
Bresnahan disclosed $1.4M of cash on hand at the end of the filing period. This was the 283rd most from all Q4 reports we have seen this year.
You can see the disclosure here, or track Robert Bresnahan's fundraising on Quiver Quantitative.
Robert Bresnahan Net Worth
Quiver Quantitative estimates that Robert Bresnahan is worth $36.4M, as of April 8th, 2026. This is the 38th highest net worth in Congress, per our live estimates.
Bresnahan has approximately $12.4M invested in publicly traded assets which Quiver is able to track live.
You can track Robert Bresnahan's net worth on Quiver Quantitative's politician page for Bresnahan.
Robert Bresnahan Bill Proposals
Here are some bills which have recently been proposed by Robert Bresnahan:
- H.R.7488: CFTC Office of the Chief Economist Act of 2026
- H.R.6934: National Flood Insurance Program Affordability Act
- H.R.6075: Water Infrastructure Modernization Act of 2025
- H.R.6022: Sgt. Walter F. Hartnett IV Green Star Veterans Service Act
- H.R.5905: Helping Our Heroes Act
- H.R.5836: Keep WIC Working Act
You can track bills proposed by Robert Bresnahan on Quiver Quantitative's politician page for Bresnahan.
2026 Pennsylvania's 8th Congressional District Election
There has been approximately $44,219,114 of spending in Pennsylvania's 8th congressional district elections over the last two years, per our estimates.
Approximately $32,279,706 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:
- HMP ($13,330,391)
- CONGRESSIONAL LEADERSHIP FUND ($7,408,898)
- DCCC ($5,770,508)
- NRCC ($1,967,623)
- AMERICANS FOR PROSPERITY ACTION, INC. (AFP ACTION) DBA CVA ACTION AND DBA LIBRE ACTION ($1,307,112)
The rating for this race is currently "Toss Up".
You can track this election on our matchup page for the 2026 Pennsylvania's 8th congressional district election.
